Form D · Other Investment Fund

GMO TRUST ON BEHALF OF ITS SERIES GMO SPECIAL PURPOSE HOLDING FUND

Boston, MA · CIK 0001460423

Offering snapshot reported Mar 14, 2011 · SEC filing

Reported sold: $277K
Investors reported: 15
Minimum accepted: $0
First sale: Dec 31, 1999

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$304,739 → $277,035
Reported investors14 → 15

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 14, 2011	Amendment	$277,035	-$27,704vs Mar 16, 2010	15	SEC filing
Mar 16, 2010	Amendment	$304,739	No comparison	14	SEC filing
Mar 16, 2009	Paper	Not reported	No comparison	Not reported
Mar 16, 2009	Paper	Not reported	No comparison	Not reported

Offering details

Securities: Other
Exemptions: 06
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-129282

SHARES

Source: Form D, filed Mar 14, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Paul Braverman	Executive
Sheppard N. Burnett	Executive
Donald W. Glazer	Executive
Joseph B. Kittredge	Executive
W. Nicholas Thorndike	Executive
Peter Tufano	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

40 Rowes Wharf
Boston, MA, 02110